Snapshots of our brain in action reveal its form and function, from molecules and cells to the grand orchestration of complex systems. The multidisciplinary symposium What Do We Want to See in Brain Imaging? will highlight recent technological achievements as attendees explore the potential for neuroimaging to revolutionize our understanding of the mind. 12/3 & 12/4 - London http://edab.dana.org/brain-imaging_en.cfm On this day in 1955 the U.S. Food and Drug Administration approved the stimulant methylphenidate—sold as Ritalin—for the treatment of ailments such as depression, chronic fatigue and narcolepsy. During the 1960s the drug was found to help people with “hyperkinetic syndrome,” known today as attention-deficit hyperactivity disorder (ADHD) and now widely diagnosed in children. Recent experiments indicate that Ritalin may work by boosting levels of dopamine in the brain, helping to focus attention. 12/5
On this day in 1955 the U.S. Food and Drug Administration approved the stimulant methylphenidate—sold as Ritalin—for the treatment of ailments such as depression, chronic fatigue and narcolepsy. During the 1960s the drug was found to help people with “hyperkinetic syndrome,” known today as attention-deficit hyperactivity disorder (ADHD) and now widely diagnosed in children. Recent experiments indicate that Ritalin may work by boosting levels of dopamine in the brain, helping to focus attention. 12/5
